Search

Your search keyword '"Tapentadol administration & dosage"' showing total 32 results

Search Constraints

Start Over You searched for: Descriptor "Tapentadol administration & dosage" Remove constraint Descriptor: "Tapentadol administration & dosage" Database MEDLINE Remove constraint Database: MEDLINE
32 results on '"Tapentadol administration & dosage"'

Search Results

1. Health-Related Quality of Life in Chronic Pain Treated With Tapentadol Versus Oxycodone/Naloxone and Its Determinants: A Real-World, Single-Center Retrospective Cohort Study in Spain.

2. Comparison of pharmacotherapeutic analgesic response and safety profile of tapentadol with other opioids.

3. Letter to the Editor re Tapentadol Versus Oxycodone for Opioid-related Adverse Drug Events and Clinical Outcomes After Inpatient Surgery.

4. Intranasal Tapentadol Versus Intravenous Paracetamol for Postoperative Analgesia in Lower Limb Orthopaedic Surgeries Under Spinal Anaesthesia: A Single Blind RCT.

5. Hallucinations Following Intravenous Use of Tapentadol.

6. DN4 questionnaire as a useful tool for evaluating the pharmacotherapeutic response to opioid pharmacotherapy in malignant neuropathy.

7. Pain control and functional recovery as therapeutic goals in patients with chronic musculoskeletal pain: two experiences with tapentadol hydrochloride.

8. Tapentadol dependence through intravenous injection ('shooting') of crushed tablets associated with cutaneous pseudoallergic reactions.

9. Tapentadol results in less deterioration of gastrointestinal function and symptoms than standard opioid therapy in healthy male volunteers.

10. The effects of tapentadol and oxycodone on central processing of tonic pain.

11. Antinociception and less gastric injury with the dexketoprofen-tapentadol combination in mice.

12. Sublingual delivery of chondroitin sulfate conjugated tapentadol loaded nanovesicles for the treatment of osteoarthritis.

13. Quality of life and functional outcomes with tapentadol prolonged release in chronic musculoskeletal pain: post hoc analysis.

14. Tapentadol, Buprenorphine, and Levorphanol for the Treatment of Neuropathic Pain: a Systematic Review.

15. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.

16. Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment-A retrospective claims analysis.

17. Tapentadol prolonged release for managing moderate to severe chronic neck pain with or without a neuropathic component.

18. Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of life.

19. Tapentadol abuse and dependence in India.

20. Tapentadol prolonged release in fragile geriatric patients > 70 years with chronic severe musculoskeletal pain: an open-label, prospective, observational study.

21. Tapentadol prolonged release in the treatment of musculoskeletal pain: an innovative pharmacological option.

22. Efficacy and tolerability of tapentadol prolonged release during rehabilitation: a prospective, observational study.

23. Tapentadol prolonged release in association with analgesic radiofrequency for the treatment of chronic lumbar radicular pain: an observational, prospective study.

24. Tapentadol prolonged release and the long-term management of chronic musculoskeletal pain in the elderly - focus on anxiety, depression, cognitive status and life quality: the TaPE study.

25. Tapentadol prolonged release for pain control in a frail obese patient: a case report.

26. Efficacy of tapentadol prolonged release for pre- and post-operative low back pain: a prospective observational study.

27. Tapentadol Dependence: A Case Series.

28. A randomized controlled trial comparing tapentadol with oxycodone in non-breastfeeding women post elective cesarean section.

29. Outcomes Associated with Treatment of Chronic Pain with Tapentadol Compared with Morphine and Oxycodone: A UK Primary Care Observational Study.

30. Participation of ATP-sensitive K+ channels and μ-opioid receptors in the antinociceptive synergism of the paracetamol-tapentadol co-administration in the formalin-induced pain assay in mice.

31. Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trials.

32. Tapentadol Prolonged Release: A Review in Pain Management.

Catalog

Books, media, physical & digital resources